Quadrant Capital Group LLC Revolution Medicines, Inc. Transaction History
Quadrant Capital Group LLC
- $2.72 Billion
- Q2 2025
Shares
4 transactions
Others Institutions Holding RVMD
# of Institutions
325Shares Held
193MCall Options Held
869KPut Options Held
715K-
Vanguard Group Inc Valley Forge, PA15.8MShares$556 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.3MShares$505 Million2.37% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$473 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$373 Million0.2% of portfolio
-
Wellington Management Group LLP Boston, MA10.3MShares$362 Million0.07% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.09B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...